INS and metabolic dysfunction-associated steatotic liver disease: Since the de novo lipogenesis rate is higher in human NAFLD than that of normal subjects [49], our results suggest down-regulation of the CDK8-CycC complex by mTORC1 as an important contributing factor to the observed increase of hepatic de novo lipogenesis in NAFLD and insulin resistant states.